Current status and recommendations for biomarkers and biobanking in neurofibromatosis

OBJECTIVE: Clinically validated biomarkers for neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2), and schwannomatosis (SWN) have not been identified to date. The biomarker working group's goals are to (1) define biomarker needs in NF1, NF2, and SWN; (2) summarize existing data on biomarkers...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neurology
Prif Awduron: Hanemann, C. Oliver, Blakeley, Jaishri O., Nunes, Fabio P., Robertson, Kent, Stemmer-Rachamimov, Anat, Mautner, Victor, Kurtz, Andreas, Ferguson, Michael, Widemann, Brigitte C., Evans, D. Gareth, Ferner, Rosalie, Carroll, Steven L., Korf, Bruce, Wolkenstein, Pierre, Knight, Pamela, Plotkin, Scott R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578360/
https://ncbi.nlm.nih.gov/pubmed/27527649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002932
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg